nalmefene associated_with somnolence
Evidence from:
primary |
all sources
Evidence (1 sources)
The adverse events reported most commonly with nalmefene (vs. placebo) were somnolence (5.2% vs. 2.9%)
confidence: 0.96
The adverse events reported most commonly with nalmefene (vs. placebo) were somnolence (5.2% vs. 2.9%)